Industry Supported Sessions - CORA 2015


​​​(Industry supported sessions are not included in the main event CME/CPD accreditation)


Thursday 12 March, 12:00 – 13:30  Hall A

ABBVIE - Articular involvement in Inflammatory Bowel Diseases

Chairman: Sarzi-Puttini and Sandro Ardizzone

Speaker : Gastroenterologist

Sandro Ardizzone (Milano)


Piercarlo Sarzi-Puttini (Milano)

ABBVIE - Cardiovascular risk and biologic agents 

Anti-rheumatic drugs and comorbidities in rheumatic diseases

Introduction: The potential effect of therapy on comorbidities in rheumatic diseases. PL Meroni (Italy)

Talk: Effect of TNF inhibitor and metothrexate on cholesterol trafficking in macrophages from patients with rheumatoid arthritis. 
N Ronda (Italy)


Thursday 12 March, 16:30 – 17:00  Hall A

MERCK - Long-term maintenance with anti-TNF Alpha in psoriasic diseases

Speaker:      Raffaele Scarpa


Thursday 12 March, 17:00 – 17:30  Hall A

HOSPIRA - Infliximab : the long and winding road

Chairman:        Atzeni Fabiola

Speaker:          Piercarlo Sarzi-Puttini


Friday 13 March, 07:45 – 08:45  Hall A

PFIZER - Immunogenicity and biologic agents

Chairman :       Andrea Doria

Speaker:          Immunogenicity of TNF inhibitors​, Pierluigi Meroni


​Friday 13 March, 12:30 – 13:30  Hall A

GSK - Managing SLE patients: evidence for progress

Chairman:        Andrea Doria

Speaker:          Disease activity in SLE - an important measure in patient                                             management, Andrea Doria

Roundtable:    Belimumab in clinical practice: what do the data tell us?

                        Andrea Doria (Italy)

                        Andreas Schwarting (Germany)

                        Jaime Calvo (Spain)


Saturday 14 March, 07:30 – 08:30  Hall A

BMS - Abatacept: which clinical criteria and which patient?

Chairmen :      Piercarlo Sarzi-Puttini

Speakers:        Co-stimulation modulation vs TNF inhibition in RA: when the evidence informs practice Gianfranco Ferraccioli

                        Lesson learned from real life: which patient for abatacept? Roberto Caporali


Saturday 14 March, 15:30 – 16:00  Hall A


Speaker:              ANA testing using chemiluminescence technology: An attractive alternative to indirect immunofluorescence?   Michael Mahler (USA)

Speaker:              Anti-CarP antibodies: A novel predictive, diagnostic and prognostic biomarker for early rheumatoid arthritis.  Pier Luigi Meroni (Italy)​

Keep Me Updated